Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satdarshan P Monga

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
American Journal of Physiology. Renal Physiology|May 1, 2015
Muc1 is protective during kidney ischemia-reperfusion injuryNúria M Pastor-Soler, Timothy A Sutton, Henry E Mang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2025
The progressively exhausted T cell response to a poorly immunogenic model of HCC can be partially rescued by immune checkpoint blockade and is heavily suppressed by T cell responses to oncolytic virotherapyThanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al.
Metabolites|June 23, 2022
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting StrategiesDaniel E Lefever, Mark T Miedel, Fen Pei, et al.
The Journal of Clinical Investigation|June 14, 2022
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitisSojin Lee, Taofeek O Usman, Jun Yamauchi, et al.
The American Journal of Pathology|October 18, 2015
Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation ProgramsJohn F Eisses, Angela Criscimanna, Zachary R Dionise, et al.
Gastroenterology|April 30, 2022
β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in CholangiocarcinomaYi Zhang, Hongwei Xu, Guofei Cui, et al.
Cell Reports|July 7, 2021
Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitorsLaura M Molina, Junjie Zhu, Qin Li, et al.
Molecular and Cellular Biology|May 30, 2019
Impaired Ribosomal Biogenesis by Noncanonical Degradation of β-Catenin during HyperammonemiaGangarao Davuluri, Michela Giusto, Rajeev Chandel, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Cancer Discovery|June 13, 2019
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular CarcinomaMarina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
American Journal of Physiology. Renal Physiology|May 1, 2015
Muc1 is protective during kidney ischemia-reperfusion injuryNúria M Pastor-Soler, Timothy A Sutton, Henry E Mang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2025
The progressively exhausted T cell response to a poorly immunogenic model of HCC can be partially rescued by immune checkpoint blockade and is heavily suppressed by T cell responses to oncolytic virotherapyThanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al.
Metabolites|June 23, 2022
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting StrategiesDaniel E Lefever, Mark T Miedel, Fen Pei, et al.
The Journal of Clinical Investigation|June 14, 2022
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitisSojin Lee, Taofeek O Usman, Jun Yamauchi, et al.
The American Journal of Pathology|October 18, 2015
Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation ProgramsJohn F Eisses, Angela Criscimanna, Zachary R Dionise, et al.
Gastroenterology|April 30, 2022
β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in CholangiocarcinomaYi Zhang, Hongwei Xu, Guofei Cui, et al.
Cell Reports|July 7, 2021
Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitorsLaura M Molina, Junjie Zhu, Qin Li, et al.
Molecular and Cellular Biology|May 30, 2019
Impaired Ribosomal Biogenesis by Noncanonical Degradation of β-Catenin during HyperammonemiaGangarao Davuluri, Michela Giusto, Rajeev Chandel, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Cancer Discovery|June 13, 2019
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular CarcinomaMarina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, et al.
Pageof 15